8Stuart J D,Lee F W,Simpson-Noel D,et al.PHarmacokinetie Parameters and mechanisms of rat type 1 and 2 steroid 5 alpha-reduce-tases:determinants for differentiin vivo activities of c1198745 and finasfereride in the rat boil[J].Chen,2001,162:933-942. 被引量：1
1Berry SJ,Coffey DS,Walsh PC,et al.The development of human benign prostatic hyperplasia with age[J].J Urol,1984,132: 474 - 479. 被引量：1
2Chung BH,Yang KM,Hong SJ.Meta- analysis of alpha receptor antagosist for benign prostatic hyperplasia from papers that were published in Korea[J].Korean J Urol,2005,46: 252 - 258. 被引量：1
3Lepor H,Auerbach S,Puras- Baez A,et al.A randomized,placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia[J].J Urol,1992,148: 1467 - 1474. 被引量：1
4Ahn SH,Chang IH,Kyung DK,et al.2009 the impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades[J].Korean J Urol,2012,53:23 - 28. 被引量：1
5Starkman JS,Santucci RA.Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy:shorter stay,earlier catheter removal and fewer complications[J].BJU Int,2005,95: 69 - 71. 被引量：1
6Bhansali M,Patankar S,Dobhada S,et al.Management of large (> 60 g)prostate gland: PlasmaKinetic Superpulse(bipolar) versus conventional(monopolar) transurethral resection of the prostate[J].J Endourol,2009,23: 141 - 145. 被引量：1
7Tan AH,Gilling PJ.Lasers in the treatment of benign prostatic hyperplasia:an update[J].Curr Opin Urol,2005,15: 55 - 58. 被引量：1
8Reich O,Gratzke C,Stief CG.Techniques and long- term,results of surgical procedures for BPH[J].Eur Urol .2006,49: 970 - 978. 被引量：1
9Mebust WK,Holtgrewe HL,Cockett AT,et al.Transurethral prostatectomy:immediate and post- operative complications.A co-operative study of 13 participating institutions evaluating 3,885 patients [J].J Urol,1989,141: 243 - 247. 被引量：1
